Lantern Pharma Inc.

Q2 2020 13F Holders

Symbol
LTRN
CUSIP
51654W101
Type
Equity
Class
COM
Num filings
6
Total reported value, excl. options
$1.55 M
Manager Report Date Value ($000) Shares Option Type